期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
A novel bellidifolin intervention mitigates nonalcoholic fatty liver disease-like changes induced by bisphenol F
1
作者 Jing Xue linwei zhang +11 位作者 Jingxian Tao Xuexue Xie Xi Wang Linlin Wu Shuhu Du Ninghua Tan Yang Jin Jianming Ju Junting Fan Jun Wang Fei Huan Rong Gao 《Journal of Biomedical Research》 CAS CSCD 2024年第5期451-463,共13页
As a potential endocrine-disrupting chemical,bisphenol F(BPF)may cause nonalcoholic fatty liver disease(NAFLD)-like changes,but the mechanisms under its pathogenesis as well as the intervention strategies remain uncle... As a potential endocrine-disrupting chemical,bisphenol F(BPF)may cause nonalcoholic fatty liver disease(NAFLD)-like changes,but the mechanisms under its pathogenesis as well as the intervention strategies remain unclear.Using the electron microscopy technology,along with LipidTOX Deep Red neutral and Bodipy 493/503 staining assays,we observed that BPF treatment elicited a striking accumulation of lipid droplets in HepG2 cells,accompanied by an increased total level of triglycerides.At the molecular level,the lipogenesis-associated mRNAs and proteins,including acetyl-CoA carboxylase,fatty acid synthase,stearoyl-CoA desaturase-1,peroxisome proliferator-activated receptor gamma,and CCAAT-enhancer-binding proteins,increased significantly via the AMP-activated protein kinase(AMPK)-mammalian target of rapamycin(mTOR)signaling regulation in both in vitro and in vivo studies.Furthermore,the immunofluorescence results also showed the robust lipogenesis induced by BPF,evident in its ability to promote the translocation of sterol regulatory element-binding protein-1c from the cytoplasm to the nuclei.To investigate the intervention strategies for BPF-induced NAFLD-like changes,we demonstrated that bellidifolin,isolated and purified from Swertia chirayita,significantly attenuated BPF-induced lipid droplet deposition in HepG2 cells and NAFLD-like changes in mice by blocking the expression of lipogenesis-associated proteins.Therefore,the present study elucidates the mechanisms underlying the BPF-induced lipid accumulation in HepG2 cells,while also highlighting the potential of bellidifolin to mitigate BPF-induced NAFLD-like changes. 展开更多
关键词 bisphenol F LIPOGENESIS non-alcoholic fatty liver disease bellidifolin
下载PDF
治疗前血清载脂蛋白水平与小细胞肺癌患者预后的相关性研究 被引量:4
2
作者 董娅 王浩澄 +2 位作者 单东凤 张林薇 于壮 《中国肺癌杂志》 CAS CSCD 北大核心 2020年第10期845-851,共7页
背景与目的肺癌为癌症相关死亡的主要原因,在所有类型的肺癌中,小细胞肺癌(small cell lung cancer, SCLC)预后极差,本研究评估SCLC患者血清载脂蛋白水平与预后的关系,寻求指导SCLC诊治的新指标。方法本研究回顾性分析了122例SCLC患者... 背景与目的肺癌为癌症相关死亡的主要原因,在所有类型的肺癌中,小细胞肺癌(small cell lung cancer, SCLC)预后极差,本研究评估SCLC患者血清载脂蛋白水平与预后的关系,寻求指导SCLC诊治的新指标。方法本研究回顾性分析了122例SCLC患者的临床资料。收集治疗前2周内血清载脂蛋白水平患者的临床结果,主要包括载脂蛋白(apolipoprotein, Apo)A-I、ApoB以及ApoB/ApoA-I。患者的无进展生存期(progression free survival, PFS)和总生存期(overall survival, OS)是主要的结局指标。用X-tile工具确定各指标的最佳临界值,生存分析采用KaplanMeier法分析,采用Cox回归分析法进行单因素分析和多因素分析。结果与低ApoA-I水平组的患者相比,高ApoA-I水平组(ApoA-I>1.12 g/L)的患者具有更好的OS(21.5个月vs 12.3个月,P=0.007)和PFS(7.3个月vs 5.5个月,P=0.017)。相反,具有较高ApoB/ApoA-I水平的患者比ApoB/ApoA-I水平较低的患者的中位OS差(13.4个月vs 20.7个月,P=0.012)。多因素Cox回归分析表明,ApoA-I是影响SCLC患者PFS的独立预后因素(HR=0.67, 95%CI:0.45-0.99,P=0.043)。ApoB/ApoA-I是影响SCLC患者OS的独立危险因素(HR=1.98, 95%CI:1.21-3.23, P=0.007)。结论治疗前血清ApoA-I水平和ApoB/ApoA-I水平可能是SCLC的重要预后因素,有助于判断患者的预后。 展开更多
关键词 肺肿瘤 载脂蛋白A-I 载脂蛋白B/载脂蛋白A-I 预后
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部